KATE BELFIORE: Open Payments
NPI 1861865313 · BROOKVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,490 in 87 payments from 25 companies in 2025. Trend: 2023 $881 · 2024 $1,140 · 2025 $1,490
Food & beverage: $1,490
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $194 |
| Novo Nordisk Inc | 11 | $175 |
| Lilly USA, LLC | 7 | $121 |
| ABBVIE INC. | 6 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $104 |
| Phathom Pharmaceuticals, Inc. | 5 | $87 |
| SHIELD THERAPEUTICS INC | 5 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $65 |
| Abbott Laboratories | 3 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
Products named: JARDIANCE, OTEZLA, Ozempic, VOQUEZNA, MOUNJARO, ACCRUFER, EVENITY, UBRELVY.
Industry payments across PA — which companies pay providers there.
